Percorso Inks Commercialization Deal with Generation Biotech | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Percorso Life Sciences announced an agreement today to commercialize Generation Biotech's SNPSeq products and help develop its business.

Generation Biotech, based in Lawrenceville, NJ., develops tools for DNA analysis. According to a statement, its proprietary bead-based haplotype- and region-specific extraction technology allows for the sequence-specific isolation of DNA segments.

Terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.